Research Solutions (RSSS) stock price is $2.00, unchanged on the day, as of Oct 19, 2026. It has a market cap of $63.58Mn and a P/E ratio of 22.53, and is classified in the Healthcare IT industry (Technology sector).
Enterprise Value
Margins
P/FCF
Key Stats
Market Cap63.58 Mn
P/E22.53
P/S1.32
Div. Yield0.00
Revenue Growth (1y) (Qtr)-2.87
Add ratio to table…
About
Research Solutions, Inc. is a vertical software as a service and artificial intelligence company that provides software and related services to help research intensive organizations simplify the research process save time and reduce costs. The company offers a suite of cloud based platforms that enable discovery access and management of scientific technical and medical content as well as transactional delivery of individual articles. Its discovery tools allow users to search…
Research Solutions, Inc. is a vertical software as a service and artificial intelligence company that provides software and related services to help research intensive organizations simplify the research process save time and reduce costs. The company offers a suite of cloud based platforms that enable discovery access and management of scientific technical and medical content as well as transactional delivery of individual articles. Its discovery tools allow users to search across millions of scholarly articles and identify relevant literature using basic and advanced search functions. The access module helps organizations manage their existing subscriptions and obtain articles at the lowest possible cost while ensuring copyright compliance for reuse in research and AI applications. The manage module provides reference management capabilities that let researchers organize documents collaborate with teammates and integrate with internal systems. Artificial intelligence features are embedded throughout the platform to improve search relevance summarize content and support literature review activities.
Revenue is generated from two main sources subscription fees for access to the company's platforms and transactional fees for the delivery of scientific technical and medical articles. Customers pay subscription fees on an annual or multi year basis, while article purchases are billed per transaction either through monthly invoicing or credit card payments. The company also earns copyright fees that accompany article delivery to ensure compliance with publishing rights. Subscription revenue provides a predictable recurring base that is recognized ratably over the contract term. Transactional revenue fluctuates with the volume of articles requested by customers and is recognized at the point of delivery. Together these streams allow Research Solutions, Inc. to serve both institutional clients that prefer ongoing access and individual researchers who need occasional articles.
Research Solutions, Inc. competes in a market that includes traditional document delivery providers such as Copyright Clearance Center and regional interlibrary loan networks, as well as reference management applications and in house solutions developed by publishers or end users. The company differentiates itself through its proprietary software platform that integrates discovery access management and artificial intelligence capabilities into a single multi tenant service. Its strong relationships with hundreds of content publishers enable rapid electronic delivery of articles, while its AI driven tools improve search relevance and reduce the time researchers spend evaluating literature. Customer loyalty is high reflected in low churn rates and the company's consistent top rankings in industry satisfaction surveys. Scalability of the cloud based architecture allows the firm to add new users without significant additional infrastructure costs. The combination of proprietary technology, publisher access, and AI functionality creates a barrier to entry for potential competitors.
The company serves corporate academic government and individual researchers across industries such as pharmaceuticals, biotechnology, medical devices, aerospace, automotive, electronics, chemicals, and agriculture. No single customer accounted for more than 10% of revenue in the most recent fiscal year indicating a diversified base. Its clients include universities, pharmaceutical corporations, government research labs, and independent scientists who rely on the platform for their daily workflow. Geographic reach extends to North America, Europe, Asia, and other regions where research intensive organizations operate.
Sector:TechnologySector rationaleThe company is a vertical software-as-a-service (SaaS) and AI provider that sells cloud-based platforms for the discovery, access, and management of scientific content. Its revenue is primarily driven by software subscription fees and transactional fees for the delivery of articles via its proprietary platform, fitting the profile of a technology company providing business process automation and analytics software.Industries:Healthcare ITHealthcare ITPrimaryResearch Solutions provides a suite of cloud-based platforms specifically designed for the discovery, access, and management of scientific, technical, and medical content. The software is purpose-built for research-intensive organizations in pharmaceuticals, biotechnology, and medical devices, embedding workflows for copyright compliance and literature review that are specific to the life sciences and medical research sectors.Productivity SoftwareProductivity SoftwareSecondaryThe company's 'manage' module provides reference management capabilities that allow researchers to organize documents and collaborate with teammates, which functions as a productivity and knowledge base tool for research teams.Classified using BQ-MICSCIK: 0001386301
Bull & bear
Investment Thesis
▲ Bull case
Research Solutions is positioned for accelerated growth through its strategic expansion into South Africa's higher education sector, where the University of Pretoria's three-year agreement for Scite serves as a beachhead for regional penetration in a market undergoing rapid digital transformation; this move leverages the company's differentiated AI-driven Smart Citations technology to address critical gaps in academic integrity and evidence-based research workflows, creating a replicable model for securing similar contracts across South Africa's 26 public universities and numerous private institutions, which collectively represent over 1.1 million students and present a multi-year runway for ARR expansion beyond the current $22.1 million base.
The launch of Article Galaxy MCP and Scite MCP integrations represents a pivotal shift toward agentic research workflows, embedding Research Solutions' core literature access and citation verification capabilities directly into dominant AI environments like ChatGPT, Claude, and Microsoft Copilot without requiring users to change their behavior; this headless SaaS approach transforms the company from a destination platform into essential infrastructure for AI-powered research, significantly increasing switching costs and expanding its total addressable market by enabling monetization through enterprise AI toolchains rather than relying solely on direct subscriptions.
Despite a slight decline in total revenue year-over-year in Q3 FY26, the company demonstrated fundamental business model improvement through a 6.69% increase in high-margin Platform subscription revenue to $5.2 million, a 220 basis point expansion in total gross margin to 51.7%, and a 297.4% surge in net income to $860,000, driven by disciplined cost control including a 58.2% reduction in stock-based compensation and improved operating leverage, indicating that the legacy transactions business drag is being actively managed while the scalable, recurring Platform business gains momentum.
Research Solutions' financial foundation is strengthening rapidly, with Adjusted EBITDA growing 14.1% year-over-year in Q3 FY26 to $1.6 million and 20.3% for the nine-month period to $4.4 million, supported by a clean balance sheet showing $12.05 million in cash and zero debt, while the reduction in contingent earnout liability payments signals decreasing acquisition-related burdens and increasing financial flexibility to reinvest in sales and marketing, which is already yielding results as evidenced by the 12.6% year-over-year growth in Platform revenue for the nine-month period.
Research Solutions is positioned for accelerated growth through its strategic expansion into South Africa's higher education sector, where the University of Pretoria's three-year agreement for Scite serves as a beachhead for regional penetration in a market undergoing rapid digital transformation; this move leverages the company's differentiated AI-driven Smart Citations technology to address critical gaps in academic integrity and evidence-based research workflows, creating a replicable model for securing similar contracts across South Africa's 26 public universities and numerous private institutions, which collectively represent over 1.1 million students and present a multi-year runway for ARR expansion beyond the current $22.1 million base.
The launch of Article Galaxy MCP and Scite MCP integrations represents a pivotal shift toward agentic research workflows, embedding Research Solutions' core literature access and citation verification capabilities directly into dominant AI environments like ChatGPT, Claude, and Microsoft Copilot without requiring users to change their behavior; this headless SaaS approach transforms the company from a destination platform into essential infrastructure for AI-powered research, significantly increasing switching costs and expanding its total addressable market by enabling monetization through enterprise AI toolchains rather than relying solely on direct subscriptions.
Despite a slight decline in total revenue year-over-year in Q3 FY26, the company demonstrated fundamental business model improvement through a 6.69% increase in high-margin Platform subscription revenue to $5.2 million, a 220 basis point expansion in total gross margin to 51.7%, and a 297.4% surge in net income to $860,000, driven by disciplined cost control including a 58.2% reduction in stock-based compensation and improved operating leverage, indicating that the legacy transactions business drag is being actively managed while the scalable, recurring Platform business gains momentum.
Research Solutions' financial foundation is strengthening rapidly, with Adjusted EBITDA growing 14.1% year-over-year in Q3 FY26 to $1.6 million and 20.3% for the nine-month period to $4.4 million, supported by a clean balance sheet showing $12.05 million in cash and zero debt, while the reduction in contingent earnout liability payments signals decreasing acquisition-related burdens and increasing financial flexibility to reinvest in sales and marketing, which is already yielding results as evidenced by the 12.6% year-over-year growth in Platform revenue for the nine-month period.
Research Solutions faces significant headwinds from the persistent decline in its lower-margin transactions revenue, which fell 11.0% year-over-year in Q3 FY26 to $7.0 million and remains the dominant revenue stream at 57.4% of total revenue, indicating that the company's core article fulfillment business continues to deteriorate due to customer churn and reduced volume from key accounts, a trend that could accelerate if academic and research institutions further consolidate their literature procurement or shift toward open-access alternatives, directly undermining the revenue base needed to fund Platform investments.
The company's growth in Platform ARR, while positive at 8.5% year-over-year to $22.1 million, is decelerating sequentially—Q3 FY26 showed only $397,970 in incremental B2B ARR compared to $735,818 in the prior-year quarter, a 45.9% decline—suggesting that new logo generation and upsell momentum may be weakening despite product launches like Article Galaxy MCP and Scite MCP, and without acceleration in this metric, the long-term target of achieving meaningful scale in the high-margin Platform business remains uncertain.
Management's strategic initiatives, including the University of Pretoria partnership and MCP integrations, lack measurable near-term financial impact, as evidenced by the absence of disclosed customer counts, ARR contributions, or revenue attribution from these specific products in the Q3 FY26 report, raising concerns that these innovations may be more aspirational than immediately contributory, particularly given the lengthy sales cycles typical in higher education and enterprise AI adoption, which could delay revenue recognition by multiple quarters.
Despite improved profitability metrics, Research Solutions' net income of $860,000 in Q3 FY26 remains modest relative to its $45.9 billion market capitalization implied valuation, and the company continues to rely on non-GAAP measures like Adjusted EBITDA to showcase performance, while GAAP net income remains sensitive to fluctuations in contingent earnout liability accounting and foreign currency translation, creating transparency risks for investors seeking to understand true underlying earnings power in a volatile macro environment affecting global research spending.
Research Solutions faces significant headwinds from the persistent decline in its lower-margin transactions revenue, which fell 11.0% year-over-year in Q3 FY26 to $7.0 million and remains the dominant revenue stream at 57.4% of total revenue, indicating that the company's core article fulfillment business continues to deteriorate due to customer churn and reduced volume from key accounts, a trend that could accelerate if academic and research institutions further consolidate their literature procurement or shift toward open-access alternatives, directly undermining the revenue base needed to fund Platform investments.
The company's growth in Platform ARR, while positive at 8.5% year-over-year to $22.1 million, is decelerating sequentially—Q3 FY26 showed only $397,970 in incremental B2B ARR compared to $735,818 in the prior-year quarter, a 45.9% decline—suggesting that new logo generation and upsell momentum may be weakening despite product launches like Article Galaxy MCP and Scite MCP, and without acceleration in this metric, the long-term target of achieving meaningful scale in the high-margin Platform business remains uncertain.
Management's strategic initiatives, including the University of Pretoria partnership and MCP integrations, lack measurable near-term financial impact, as evidenced by the absence of disclosed customer counts, ARR contributions, or revenue attribution from these specific products in the Q3 FY26 report, raising concerns that these innovations may be more aspirational than immediately contributory, particularly given the lengthy sales cycles typical in higher education and enterprise AI adoption, which could delay revenue recognition by multiple quarters.
Despite improved profitability metrics, Research Solutions' net income of $860,000 in Q3 FY26 remains modest relative to its $45.9 billion market capitalization implied valuation, and the company continues to rely on non-GAAP measures like Adjusted EBITDA to showcase performance, while GAAP net income remains sensitive to fluctuations in contingent earnout liability accounting and foreign currency translation, creating transparency risks for investors seeking to understand true underlying earnings power in a volatile macro environment affecting global research spending.